Sudden death related to toxicity in a patient on capecitabine and irinotecan plus bevacizumab intake: pharmacogenetic implications

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 30; no. 4; pp. e41 - e44
Main Authors:	Dahan, Laetitia, Ciccolini, Joseph, Evrard, Alexandre, Mbatchi, Litaty, Tibbitts, Jack, Ries, Pauline, Norguet, Emmanuelle, Mercier, Cedric, Iliadis, Athanassios, Ouafik, L'Houcine, Lacarelle, Bruno, Seitz, Jean-Francois
Format:	Journal Article
Language:	English
Published:	United States American Society of Clinical Oncology 01-02-2012
Subjects:	Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab Camptothecin - administration & dosage Camptothecin - adverse effects Camptothecin - analogs & derivatives Cancer Capecitabine Colorectal Neoplasms - drug therapy Death, Sudden - etiology Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Fluorouracil - administration & dosage Fluorouracil - adverse effects Fluorouracil - analogs & derivatives Humans Life Sciences Male Middle Aged
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0732-183X 1527-7755
DOI:	10.1200/JCO.2011.37.9289